In addition, MEF2 seems to play an important role in APP-mediated anti-apoptotic neuroprotection [12], and MEF2C is identified as a regulator of APP proteolytic process in which Amyloid-β (Aβ), one central factor to initiate AD pathogenesis, is produced [13]. Here, MEF2C is linked to Alzheimer disease.